Insiders · Profile

O'Kane Kieran

Chief Commercial Officer at BIODESIX. Filing since 10 May 2022. CIK 0001828131

Company
Date
Role
Action
Shares
Amount
Of holding
23 Feb 2026
Chief Commercial Officer
Sold at will
535
$6.83K
5.2%
10 Feb 2026
Chief Commercial Officer
Sold at will
584
$5.89K
6.2%
16 Jan 2026
Chief Commercial Officer
Sold at will
298
$2.43K
3.6%
10 Nov 2025
Chief Commercial Officer
Sold at will
25
$190.50
0.3%
13 Aug 2025
Chief Commercial Officer
Sold at will
476
$198.16
0.3%
13 May 2025
Chief Commercial Officer
Sold at will
238
$83.99
0.2%
12 May 2025
Chief Commercial Officer
Sold at will
239
$85.90
0.2%
11 Feb 2025
Chief Commercial Officer
Sold at will
17,527
$16.20K
12.0%
12 Nov 2024
Chief Commercial Officer
Sold at will
224
$313.78
0.2%
11 Nov 2024
Chief Commercial Officer
Sold at will
238
$331.03
0.2%
12 Aug 2024
Chief Commercial Officer
Sold at will
120
$188.63
0.1%
9 Aug 2024
Chief Commercial Officer
Sold at will
345
$552.35
0.4%
9 May 2024
Chief Commercial Officer
Sold at will
468
$692.41
0.6%
12 Feb 2024
Chief Commercial Officer
Sold at will
5,412
$9.01K
7.4%
9 Feb 2024
Chief Commercial Officer
Sold at will
6,319
$12.11K
7.9%
10 Nov 2023
Chief Commercial Officer
Sold at will
235
$288.02
0.5%
9 Nov 2023
Chief Commercial Officer
Sold at will
234
$297.34
0.5%
10 Aug 2023
Chief Commercial Officer
Sold at will
849
$1.08K
1.8%
9 Aug 2023
Chief Commercial Officer
Sold at will
850
$1.18K
1.8%
10 May 2023
Chief Commercial Officer
Sold at will
474
$747.07
1.3%
9 May 2023
Chief Commercial Officer
Sold at will
1,223
$1.92K
3.2%
9 Feb 2023
Chief Commercial Officer
Sold, plan not stated
1,999
$3.60K
8.0%
10 Nov 2022
Chief Commercial Officer
Sold, plan not stated
753
$766.18
4.7%
9 Nov 2022
Chief Commercial Officer
Sold, plan not stated
952
$991.79
5.6%
9 Aug 2022
Chief Commercial Officer
Sold, plan not stated
1,673
$4.23K
12.8%
10 May 2022
Chief Commercial Officer
Sold, plan not stated
1,583
$2.90K
17.2%
26 decisions on file.